EU_Neuro_Contents.qxp 18/2/09 11:04 am Page 4
Contents
Advisory Panel
8
Foreword
9
Tamás Péter Dóczi
Department of Neurosurgery, Centre for Medical and Health Sciences, Pécs Medical University
Current Issues
Evaluation of the Current Evidence on Hyperhomocysteinaemia in
Neurological Diseases 10
Rima Obeid, Klaus Fassbender and Wolfgang Herrmann
Homocysteine Expert Panel, Homocysteine Round Table Discussion, Annual Meeting of
the German Society for Clinical Chemistry, Mannheim
Age-related Neurodegenerative Disease
GSTZ1 Genotype and Cognitive Ability 15
John M Starr
1
and Catherine Quinn
2
1. Professor of Health and Ageing, MRC Centre for Cognitive Epidemiology and Cognitive Ageing,
University of Edinburgh, Royal Victoria Hospital, Edinburgh; 2. Specialist Registrar, NES South East Scotland,
Royal Victoria Hospital, Edinburgh
Alzheimer’s Disease
Alzheimer’s Disease – The Importance of Early Detection 18
Stephen Todd
1
and Peter Passmore
2
1. Beeson Scholar and Honorary Consultant Geriatrician, Belfast City Hospital;
2. Professor of Geriatric Medicine, Queen’s University Belfast, and Consultant
Physician, Care of The Elderly, Belfast City Hospital
Clinical Experience of Memantine in Alzheimer’s Disease 22
Rafael Blesa
Servei de Neurologia, Hospital Sant Pau, Barcelona
Blood Biomarkers for Alzheimer’s Disease 28
Bengt Winblad
1
and Anders Lönneborg
2
1. Professor of Geriatric Medicine, Karolinska Institute; 2. Research Director, DiaGenic ASA
Clinical Heterogeneity Associated with Tau Gene Mutations 31
AJ Larner and M Doran
Cognitive Function Clinic, Walton Centre for Neurology and Neurosurgery, Liverpool
Parkinson’s Disease
Parkinson’s Disease Therapy – When to Start and What to Choose 34
Andrew J Lees
Director, Reta Lila Weston Institute of Neurological Studies, University College London, and
Professor of Neurology, National Hospital for Neurology and Neurosurgery
Evidence for the Use of Levodopa–Carbidopa–Entacapone (STALEVO) to
Improve Motor Fluctuations in Parkinson’s Disease 37
Philippe Damier
French National Institute for Health and Medical Research (INSERM), CIC0004, UMR 643,
University Hospital Nantes, and CIC0004, Pôle Neurosciences, University Hospital Nantes
S18Y, UCH-L1 and Parkinson’s Disease 41
Andrea Carmine Belin and Dagmar Galter
Department of Neuroscience, Karolinska Institute, Stockholm
4 EUROPEAN NEUROLOGICAL REVIEW
Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68  |  Page 69  |  Page 70  |  Page 71  |  Page 72  |  Page 73  |  Page 74  |  Page 75  |  Page 76  |  Page 77  |  Page 78  |  Page 79  |  Page 80  |  Page 81  |  Page 82  |  Page 83  |  Page 84  |  Page 85  |  Page 86  |  Page 87  |  Page 88  |  Page 89  |  Page 90  |  Page 91  |  Page 92  |  Page 93  |  Page 94  |  Page 95  |  Page 96  |  Page 97  |  Page 98  |  Page 99  |  Page 100  |  Page 101  |  Page 102  |  Page 103  |  Page 104  |  Page 105  |  Page 106  |  Page 107  |  Page 108  |  Page 109  |  Page 110  |  Page 111  |  Page 112  |  Page 113  |  Page 114  |  Page 115  |  Page 116  |  Page 117  |  Page 118  |  Page 119  |  Page 120  |  Page 121  |  Page 122  |  Page 123  |  Page 124